Identification of a key residue determining substrate affinity in the human glucose transporter GLUT1  by Kasahara, Toshiko et al.
Biochimica et Biophysica Acta 1788 (2009) 1051–1055
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemIdentiﬁcation of a key residue determining substrate afﬁnity in the human glucose
transporter GLUT1
Toshiko Kasahara a, Mari Maeda a, Eckhard Boles c, Michihiro Kasahara a,b,⁎
a Laboratory of Biophysics, School of Medicine, Hachioji, Tokyo 192-0395, Japan
b Genome Research Center, Teikyo University, Hachioji, Tokyo 192-0395, Japan
c Institute of Molecular Bioscience, J. W. Goethe-University, D-60438 Frankfurt am Main, GermanyAbbreviations: ATB-BMPA, 2-N-4- (1-azi-2,2,2-tr
(D-mannos-4-yloxy) -2-propylamine; MFS, major
transmembrane segment
⁎ Corresponding author. Tel.: +81 42 678 3261; fax:
E-mail address: kasahara@main.teikyo-u.ac.jp (M. K
0005-2736/$ – see front matter © 2009 Elsevier B.V. A
doi:10.1016/j.bbamem.2009.01.014a b s t r a c ta r t i c l e i n f oArticle history: Asn331 in transmembrane
Received 8 September 2008
Received in revised form 27 January 2009
Accepted 27 January 2009
Available online 3 February 2009
Keywords:
Glucose transporter
Substrate afﬁnity
Amino acid residue
GLUT1
Hxt2segment 7 of the yeast Saccharomyces cerevisiae transporter Hxt2 has been
identiﬁed as a single key residue for high-afﬁnity glucose transport by comprehensive chimera approach. The
glucose transporter GLUT1 of mammals belongs to the same major facilitator superfamily as Hxt2 and may
therefore show a similar mechanism of substrate recognition. The functional role of Ile287 in human GLUT1,
which corresponds to Asn331 in Hxt2, was studied by its replacement with each of the other 19 amino acids.
The mutant transporters were individually expressed in a recently developed yeast expression system for
GLUT1. Replacement of Ile287 generated transporters with various afﬁnities for glucose that correlated well
with those of the corresponding mutants of the yeast transporter. Residues exhibiting high afﬁnity for
glucose were medium-sized, non-aromatic, uncharged and irrelevant to hydrogen-bond capability,
suggesting an important role of van der Waals interaction. Sensitivity to phloretin, a speciﬁc inhibitor for
the presumed exofacial glucose binding site, was decreased in two mutants, whereas that to cytochalasin B, a
speciﬁc inhibitor for the presumed endofacial glucose binding site, was unchanged in the mutants. These
results suggest that Ile287 is a key residue for maintaining high glucose afﬁnity in GLUT1 as revealed in Hxt2
and is located at or near the exofacial glucose binding site.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionGlucose is an important nutrient for most living cells. Facilitated
diffusion of glucose and related sugars across biological membranes is
mediated by monosaccharide transporters. One group of such
transporters, referred to as GLUT transporters, belongs to the major
facilitator superfamily (MFS) [1]. Human GLUT transporters are
classiﬁed in the SLC2A family, with GLUT1 (SLC2A1) being the
prototype of this family. GLUT1 is expressed in many tissues and cell
types including blood–tissue barriers and erythrocytes [2]. It remains
to date the only glucose transporter to be puriﬁed and functionally
reconstituted into liposomes [3,4].
Studies of glucose transport, which have focused on human
erythrocytes, have resulted in the identiﬁcation of several speciﬁc
inhibitors. Phloretin is a biphenolic compound and inhibits the glucose
transport activity of GLUT1 [5]. Kinetic analysis has indicated that this
compound binds competitively to a presumed exofacial glucose bindingiﬂuoroethyl) benzoyl-1,3-bis
facilitator superfamily; TM,
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ll rights reserved.site [6]. Cytochalasin B inhibits GLUT1 with kinetic analysis indicating
that it binds to a presumed endofacial glucose binding site [6].
Various mutational studies have been extensively performed on
the molecular mechanism of sugar transport by GLUT1 and other
GLUT transporters [2,7,8]. Above all, many amino acid residues in TM7
were implicated for the substrate binding [9–13].
Detailed structural insight into bacterial MFS transporters was
provided by the low resolution crystal of OxlT [14] and then the high
resolution crystals of GlpT [15], LacY [16] and EmrD [17]. The
conﬁgurations of the transmembrane segments (TMs) in these
transporters are highly similar. These ﬁndings suggest that MFS
transporters share similar conformations regardless of the substantial
differences in their amino acid sequences and substrate speciﬁcities.
The yeast Saccharomyces cerevisiae expresses 17 hexose transpor-
ters (Hxt1 to Hxt11, Hxt13 to Hxt17, and Gal2) [18,19] that belong to
the MFS and are homologs of the mammalian GLUT transporters. In
contrast to mammalian GLUT transporters, however, no speciﬁc
inhibitors, with the exception of sulfhydryl inhibitors, have been
identiﬁed for the yeast hexose transporters. We have previously
studied the yeast high-afﬁnity glucose transporter Hxt2 by generating
a comprehensive series of chimeric transporters.We found that Asn331
in TM7 is a key residue responsible for the high-afﬁnity glucose
transport activity of Hxt2 [20]. The replacement of this residue with
each of the other 19 amino acids yielded transporters with Km values
Fig.1. Expression of 287Xmutants. (A) S7 cells harboring plasmids encoding each of the
287X mutants of GLUT1 were cultured to early stationary phase at 30 °C in S2Mal
synthetic medium, after which cell homogenates were prepared. A portion of each
homogenate (5 μg of protein) was subjected to immunoblot analysis with antibodies to
GLUT1 and 125I-labeled protein A. (B) The band intensity for each mutant protein in
immunoblots similar to that shown in Awasmeasured and expressed as a percentage of
that for GLUT1 (287I). Data are means±SE from ﬁve or six experiments.
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wild-type transporter.
We have now examined the possibility that a similar mechanism of
substrate recognition might operate in the mammalian glucose
transporter GLUT1, although the amino acid identity between Hxt2
and GLUT1 is only 27% even within TM regions [21]. We thus
investigated the role of Ile287 in human GLUT1, which corresponds to
Asn331 of yeast Hxt2 [21], with the use of a recently developed
heterologous yeast expression system based on a glucose transport-
null strain of S. cerevisiae with an additional mutation to allow
expression of GLUT1 in the plasma membrane in a fully functional
form [22]. Our results indicate that Ile287 is indeed a crucial residue for
high afﬁnity of GLUT1 for glucose, suggesting that MFS transporters
may also share a common mechanism for substrate recognition.
2. Materials and methods
2.1. Construction of vectors
The plasmid GLUT1-pVT, which comprises human GLUT1 cDNA
under the control of the ADH1 promoter in the multicopy vector
pVT102-U (YEp URA3 bla), was constructed as described previously
[23]. The initiation codon of the open reading frame of GLUT1 is
replaced in this plasmid with a 45-nucleotide sequence: GGATCC
(BamHI site) –TACACA (Kozak sequence) –ATGCACCATCACCACCAT-
CAC (initiation codon followed by six histidine codons) –ATC-
GAAGGTCGT (codons for Ile-Glu-Gly-Arg as an Xa substrate). The
open reading frame of GLUT1 was also modiﬁed in this plasmid to
generate (i) a ClaI site (underline) immediately downstream of the
termination codon (by changing TGA toTAATCGAT), (ii) a SacII site (by
changing CCGCGC to CCGCGG, corresponding to nucleotides 631 to
636 of the open reading frame), and (iii) a SalI site (by changing
GCCGGC to GTCGAC, corresponding to nucleotides 995 to 1000), all
without changing the deduced amino acid sequence.
2.2. Mutagenesis
Replacement of Ile287 in GLUT1 with each of the other 19 amino
acids was performed with the use of a polymerase chain reaction-
based approach in which the target codon (ATC) was replaced with a
speciﬁc codon for each of the other 19 residues, as described
previously [20]. The ampliﬁcation products were digested with SacII
and SalI and substituted for the corresponding region of GLUT1 cDNA
in GLUT1-pVT. Plasmids were introduced into S. cerevisiae S7 (MATa
Δhxt1–17 Δgal2 Δagt1 Δmph2 Δmph3 Δstl1 leu2–3,112 ura3–52 trp1–
289 his3-Δ1 MAL2–8c SUC2 fgy1–1) [22]. The DNA sequences were
conﬁrmed for each of the mutated transporters with the use of a DNA
sequencer (model 310, Applied Biosystems).
2.3. Transport assay
Cells harboring plasmids were grown to early stationary phase
(optical density at 650 nm, 1.0 to 1.3) at 30 °C in synthetic liquid
medium supplemented with adenine, amino acids, and maltose
(20 mg/ml) but not with uracil (S2Mal) [24]. The initial rate of
glucose uptake by the cells was measured at 30 °C for 5 s in the assay
buffer of pH 6.0 as described [25,26]. Transport activities measured at
a D-[14C]glucose concentration of 0.1 or 20 mM were expressed as
picomoles of glucose per 1×107 cells per 5 s and were corrected for
the background activity determined with 0.1 or 20 mM L-[14C]glucose
as substrate. Kinetic parameters were measured under the zero-trans
entry condition and were determined by nonlinear regression
analysis. For examination of the effects of inhibitors, cells were
exposed to the inhibitor for at least 5 min at 30 °C before
measurement of transport activity. We conﬁrmed that the inhibitory
effect of phloretin was dependent on pH as described by LeFebre andMarshall [27] and our assay condition at pH 6.0 was found appropriate
(Supplemental Fig. S1). In some experiments, transport activity was
calculated as a percentage of that observed with cells expressing wild-
type GLUT1. Kinetic data for the yeast chimeric transporter C1578
were obtained previously [20].
2.4. Other assays
Cell homogenates were prepared as described [25] and were
subjected to immunoblot analysis with rabbit polyclonal antibodies
generated against human erythrocyte GLUT1 and with 125I-labeled
protein A (GE Healthcare) [28]. The intensity of bands corresponding
to immune complexes wasmeasured with imaging plates (BAS 1800II,
Fuji Film) within the range proportional to the amount of protein. Cell
number was determined with a particle counter (Z2, Beckman
Coulter). Protein concentration was measured with bicinchoninic
acid (Pierce).
3. Results and discussion
3.1. Expression of 287X mutants of GLUT1
We made use of a yeast multicopy expression plasmid containing
human GLUT1 cDNA (GLUT1-pVT) to study the role of Ile287 in the
putative TM7 of GLUT1, which corresponds to Asn331 in yeast Hxt2 and
in our yeast chimeric transporter C1578, studied previously [20, see
Supplemental Fig. S2]. Isoleucine-287 was replaced with each of the
other 19 amino acids to generate the 287X series of mutants, and each
modiﬁed GLUT1 was expressed in S. cerevisiae strain S7, in which the
genes for all known endogenous hexose transporters have been
deleted (Δhxt1–17 Δgal2) and in which the heterologous GLUT1 was
targeted to the plasmamembrane in a fully active form as a result of an
additionally introduced mutation (fgy1-1) [22]. Expression of each
mutant protein was conﬁrmed by immunoblot analysis of cell
homogenates with antibodies to GLUT1 (Fig. 1A). All the mutants
showed a predominant immunoreactive band at 40 kDa correspond-
ing to the position of wild-type GLUT1. The extent of expression of
each mutant protein was 60 to 107% of that of wild-type GLUT1, with
the exception of 287H (51%) and 287K (56%) (Fig. 1B).
Table 1
Characterization of the 287X series of GLUT1 mutants
Mutant Glucose transport (0.1 mM) Glucose transport (20 mM) Km
(mM)
Vmax Relative Vmax
pmol/5 s per 107 cells Normalized by IB pmol/5 s per 107 cells Normalized by IB (pmol/5 s per 107 cells) Normalized by IB
287G 1.4±0.2 0.07 172±21 0.74 ND ND
287A 2.6±0.2 0.10 187±11 0.63 13±2 300±10 1.04
287V 12.7±3.4 0.67 185±32 0.83 1.6±0.4 160±20 0.75
287L 8.4±0.4 0.43 230±26 1.02 3.3±0.6 230±30 1.06
287F 0.4±0.0 0.03 58±18 0.35 ND ND
287W 0.2±0.1 0.01 58±29 0.28 ND ND
287M 8.7±0.7 0.35 329±58 1.11 5.3±1.5 410±70 1.45
287C 6.7±0.6 0.29 255±45 0.94 4.4±0.6 270±50 1.03
287P 4.6±0.7 0.19 320±38 1.12 12±0 5 20±60 1.89
287S 3.3±0.3 0.15 310±48 1.16 16±3 530±130 2.07
287T 15.5 ±1.0 0.81 556±37 2.46 4.5±0.5 630±30 2.90
287Y 0.2±0.1 0.01 74±7 0.27 ND ND
287N 2.2±0.2 0.09 203±25 0.73 15±1 270±40 1.01
287Q 1.2±0.1 0.07 188±41 0.91 ND ND
287D 1.0±0.0 0.05 77±4 0.34 14±1 120±10 0.56
287E 2.5±0.3 0.14 170±6 0.77 13±3 270±30 1.26
287H 0.4±0.1 0.04 114±0 0.78 ND ND
287K 0.2±0.1 0.02 58±10 0.38 ND ND
287R 0.4±0.1 0.03 65±7 0.34 ND ND
GLUT1 (287I) 23.8±2.5 1.00 281±29 1.00 1.1±0.0 270±30 1.00
The 287Xmutants were generated by replacing Ile287 of GLUT1 with each of the other 19 amino acids and were expressed in S7 cells. The cells were grown to early stationary phase at
30 °C in S2Mal synthetic medium, after which glucose transport activity was measured for 5 s at 30 °C with 0.1 or 20 mM D-glucose as substrate. Transport activities were normalized
either by cell number or by the mean level of protein expression as determined by quantitative immunoblot (IB) analysis (Fig. 1B); the latter values are expressed relative to the
normalized value for GLUT1. The Km, Vmax, and relative Vmax (normalized by IB) were determined with 0.1 to 80 mM D-glucose as substrate as described [20]. ND, not determined.
Transport activities and kinetic parameters are means±SE from at least three experiments.
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Wild-type GLUT1 exhibited a Km for glucose of 1.1 mM (Table 1). As
a ﬁrst step to evaluate changes in the kinetics of glucose transport
mediated by the 287X series of mutants, we measured transport
activities at D-glucose concentrations of 0.1 and 20 mM and normal-
ized the measured activities by the expression level of each mutant as
determined by immunoblot analysis (Table 1). The Km and Vmax values
of the GLUT1 mutants were determined under the zero-trans entry
conditionwith 0.1 to 80mMD-glucose as substrate. Themutants could
be divided into three groups on the basis of their Kmvalues: (i) a group
of high-afﬁnity transporters (Km=1 to 6 mM) consisting of 287V,
287L, 287M, 287C, and 287 T; (ii) a group of lower-afﬁnity transporters
(Km=12 to 16 mM) consisting of 287A, 287P, 287S, 287N, 287D, and
287E; and (iii) a group of transporters whose activities were too low
for assessment of kinetic parameters, consisting of 287G, 287F, 287W,
287Y, 287Q, 287H, 287K, and 287R. The Kmvalues of the 287X series of
GLUT1 mutants correlated well with those of the 331X series of C1578Fig. 2. Correlation of glucose afﬁnities for 287X mutants of GLUT1 and those for 331X
mutants of C1578. Kinetic parameters of glucose transport for the indicated 287X
mutants of GLUT1 were measured for 5 s at 30 °C as described in Materials and methods
and Table 1. Similar measurements were previously performed with KY73 cells
expressing 331X mutants of C1578 [20]. Since the activity of 331L of C1578 was too low
for kinetic study, data for Leu is not shown.mutants (Fig. 2). The rank order of afﬁnities for the GLUT1 mutants
was 287I (wild type)N287VN287LN287C, whereas that for the C1578
mutants was 331IN331VN331C. All of these high-ranking residues are
medium-sized, non-aromatic and uncharged amino acids with a low
or no hydrogen bonding capability. Given the predicted location of
Asn331 of C1578 in the middle of TM7where the residue is surrounded
by three other residues in different TMs within van der Waals
distances [20], the size and shape of the residue at this position are
likely important for it to ﬁt well. The similar effects of residue
replacement at this position in both GLUT1 and C1578 suggest the
existence of a common structure around this site in both transporters.
Minor differences were observed between the rank order of afﬁnities
for replacement of Asn331 of C1578 and that for replacement of the
corresponding residue of Hxt2 [20].
We examined the substrate speciﬁcities of the ﬁve GLUT1 mutants
that exhibited high-afﬁnity glucose transport activity: 287V, 287L,
287M, 287C, and 287T. No marked differences in substrate speciﬁcity
were apparent between these mutants and wild-type GLUT1 (Fig. 3).Fig. 3. Substrate speciﬁcity of 287X mutants of GLUT1 exhibiting high-afﬁnity glucose
transport. The transport activities of the 287V, 287L, 287M, 287C, and 287T mutants as
well as of wild-type GLUT1 were measured at 30 °C for 5 s with 0.1 mM D-[14C]glucose
as substrate in the presence of 20mMnonradioactive sugar indicated. Glucose transport
activity for each mutant was expressed as a percentage of that determined in the
presence of 20 mM L-glucose. Data are means±SE from four experiments. D-Glc, D-
glucose; 2DG, 2-deoxy-D-glucose; 6DG, 6-deoxy-D-glucose; D-Man, D-mannose; 3OMG,
3-O-methyl-D-glucose; D-Gal, D-galactose; D-Fru, D-fructose.
Fig. 4. Lineweaver–Burk plots of glucose transport activity of GLUT1 and the 287C mutant in the presence of phloretin or cytochalasin B. The transport activities of GLUT1 (A, B) and
the 287C mutant of GLUT1 (C, D) were measured at 30 °C for 5 s (GLUT1) or for 10 s (287C) with 0.1 to 1.0 mM D-[14C]glucose as substrate and in the presence of the indicated
concentrations of phloretin (A, C) or cytochalasin B (B, D). The inset in C shows the portion of the graph close to the origin.
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We next investigated the effects of two potent inhibitors thought to
bind asymmetrically toGLUT1. Kinetic analysis has shown that phloretin
and cytochalasinB bind to exofacial and endofacial glucosebinding sites,
respectively [6]. Under the zero-trans entry condition, phloretin
competitively inhibits glucose transport whereas cytochalasin B acts
as a noncompetitive inhibitor. We conﬁrmed that phloretin and
cytochalasin B acted as competitive and noncompetitive inhibitors,
respectively, of glucose entry inyeast cells expressingGLUT1 (Fig. 4A, B).
The same patterns of inhibitionwere observed with the GLUT1 mutant
287C (Fig. 4C, D). Table 2 shows Ki values for seven mutants: ﬁve high-
afﬁnity mutants (287V, 287L, 287M, 287C, and 287T) and two lower-
afﬁnity mutants (287P and 287S). The sensitivity to phloretin was
markedly reduced for 287C and 287S compared with that for GLUT1,
whereas that to cytochalasin B did not differ substantially between theTable 2
Inhibition constant (Ki) values of 287X mutants for phloretin and cytochalasin B
Mutant Ki for phloretin (μM) Ki for cytochalasin B (μM)
287V 3.3±0.0 1.2±0.3
287L 3.3±0.5 2.1±0.3
287M 4.5±0.1 2.2±0.3
287C 22±4 1.5±0.3
287P 5.3±0.3 1.7±0.2
287S 42±4 5.0±1.5
287T 6.0±1.7 4.8±2.3
GLUT1 (287I) 3.0±0.5 2.0±0.3
S7 cells expressing the indicated 287Xmutants of GLUT1were grown to early stationary
phase at 30 °C in S2Mal synthetic medium. Glucose transport activity was measured for
5 s at 30 °C with 0.1 mM D-glucose as substrate and in the absence or presence of
phloretin (1 to 100 μM) or cytochalasin B (0.5 to 10 μM). The Ki values for phloretin and
cytochalasin B were calculated based on competitive and noncompetitive inhibition,
respectively, and are means±SE from three or four experiments.examined mutants and GLUT1. The reason why only the phloretin Ki
values of 287C and 287S were increased is not clear, but our results are
consistent with the notion that Ile287 of GLUT1 is located close to or at
the exofacial glucose binding site and is a key residue for maintaining
glucose afﬁnity. Given that, with the exception of 287V (0.75) and
287D (0.56), the relative Vmax values of 287X mutants, regardless of
their afﬁnity for glucose, were approximately equal to or greater than
that of the wild-type protein (Table 1), it is not likely that the
replacement of Ile with most other residues alters the basic high-
afﬁnity structure of the transporter or impairs its targeting to the
plasma membrane, although these possibilities cannot be excluded.
3.4. Important role of TM7
The role of TM7 in transport function has been previously studied
in members of the mammalian GLUT family. For GLUT1, the
substitution of Leu for Gln282, which is situated about one helix
turn below Ile287 (Fig. 5), and the use of inhibitors (4,6-O-ethylidene
D-glucose and ATB-BMPA) speciﬁc for the exofacial glucose binding
site suggested that this residue is important for transport and that it
faces the hydrophilic side of the permeation pathway either at or
close to the exofacial site [9]. The replacement of Ile287 with Cys in a
cysteine-less form of GLUT1 and examination of the effects of a
hydrophilic sulfhydryl inhibitor (p-chloromercuribenzenesulfonate)
and of N-ethyl maleimide indicated that this residue is also
important for transport and faces the hydrophilic side [11,12]. Studies
with GLUT2 and GLUT3 suggested that the QLS motif present in the
middle of TM7 (corresponds to Q279, L280 and S281 of GLUT1)
interacts with the C-1 position of D-glucose [10]. In GLUT7, a fructose
and glucose transporter, Ile314, which corresponds to Val290 of GLUT1
and is situated at the outer edge of TM7, was shown to be required
for fructose transport [13]. In addition, analysis of a plant
monosaccharide transporter, Chlorella HUP1, showed that
Fig. 5. Amino acid residues in TM7 implicated for functional roles. TM7 is shown as α-
helix. Amino acid residues pointed out as functionally important in previous studies and
Ile287 are shown in ball and stick representation.
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increased the Km for glucose from 1.5×10−5 to 6×10−3 M without
affecting Vmax [29]. Such an increase in Kmwas also observed for 287N
in the present study. Studies of bacterial MFS transporters have also
shown the importance of TM7. TM7 thus contributes to the substrate
permeation pathway in the crystal structures of GlpT and LacY [15,16],
and one of the putative substrate binding sites (Arg269) in TM7 of GlpT
corresponds to Gln283 of GLUT1. These various observations thus
indicate that TM7 plays a key role in substrate recognition by MFS
transporters.
4. Conclusion
We observed that in GLUT1, medium-sized, non-aromatic and
uncharged residues arewell accommodated at position of 287. Among
17 homologs of Saccharomyces cerevisiae, we recognized Asp and Glu
also accommodated in this position (Supplemental Fig. S2). Thus, it
appears that “medium-size” is a general feature of the residue at this
position, suggesting that hydrogen bonding at this position does not
contribute to high-afﬁnity glucose transport. We propose that Ile287
interacts with surrounding residues within van der Waals distance
that directly communicate with the substrate and thereby contributes
to ﬁne-tuning of the binding reaction at the presumed exofacial site.
Alternative possibilities are that this residue contributes to steric
hindrance of the passing substrate or that it may serve for the dynamic
movement of the transporter caused by substrate binding.
Our present data have shown that Ile287 of the human glucose
transporter GLUT1, like the corresponding residue (Asn331) of the
yeast glucose transporter Hxt2, is a key residue for determining high
glucose afﬁnity in GLUT1. In addition, the effects of phloretin and
cytochalasin B support the notion that Ile287 of GLUT1 is located at or
close to the presumed exofacial binding site for glucose.
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